Intellia Therapeutics, Inc. (NTLA)
9.37
+0.07
(+0.75%)
USD |
NASDAQ |
Dec 10, 16:00
9.37
0.00 (0.00%)
After-Hours: 20:00
Intellia Therapeutics Market Cap: 1.085B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.842B |
| Regeneron Pharmaceuticals, Inc. | 76.32B |
| Beam Therapeutics, Inc. | 2.780B |
| Vertex Pharmaceuticals, Inc. | 112.81B |
| Pacific Biosciences of California, Inc. | 715.52M |
Market Cap Related Metrics
| PS Ratio | 17.07 |
| Price to Book Value | 1.450 |
| Price | 9.37 |
| Earnings Yield | -45.53% |